Strategies for the Development & Evaluation of Treatments for Children with Renal Diseases

• Review ethical and legal obligations in studying drugs in children 
• Discuss unique considerations for designing paediatric drug development programs
• Present innovative tools and strategies to increase the feasibility and success of pediatric drug development programs 

Speakers:

Lynne Yao

Director DPMH/FDA

US Food & Drug Administration (FDA)